Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Zhang, E. E.
  • Liu, Y.
  • Dentin, R.
  • Pongsawakul, P. Y.
  • Liu, A. C.
  • Hirota, T.
  • Nusinow, D. A.
  • Sun, X.
  • Landais, S.
  • Kodama, Y.
  • Brenner, D. A.
  • Montminy, M.
  • Kay, Steve A.

publication date

  • October 2010

journal

  • Nature Medicine  Journal

abstract

  • During fasting, mammals maintain normal glucose homeostasis by stimulating hepatic gluconeogenesis. Elevations in circulating glucagon and epinephrine, two hormones that activate hepatic gluconeogenesis, trigger the cAMP-mediated phosphorylation of cAMP response element-binding protein (Creb) and dephosphorylation of the Creb-regulated transcription coactivator-2 (Crtc2)--two key transcriptional regulators of this process. Although the underlying mechanism is unclear, hepatic gluconeogenesis is also regulated by the circadian clock, which coordinates glucose metabolism with changes in the external environment. Circadian control of gene expression is achieved by two transcriptional activators, Clock and Bmal1, which stimulate cryptochrome (Cry1 and Cry2) and Period (Per1, Per2 and Per3) repressors that feed back on Clock-Bmal1 activity. Here we show that Creb activity during fasting is modulated by Cry1 and Cry2, which are rhythmically expressed in the liver. Cry1 expression was elevated during the night-day transition, when it reduced fasting gluconeogenic gene expression by blocking glucagon-mediated increases in intracellular cAMP concentrations and in the protein kinase A-mediated phosphorylation of Creb. In biochemical reconstitution studies, we found that Cry1 inhibited accumulation of cAMP in response to G protein-coupled receptor (GPCR) activation but not to forskolin, a direct activator of adenyl cyclase. Cry proteins seemed to modulate GPCR activity directly through interaction with G(s)α. As hepatic overexpression of Cry1 lowered blood glucose concentrations and improved insulin sensitivity in insulin-resistant db/db mice, our results suggest that compounds that enhance cryptochrome activity may provide therapeutic benefit to individuals with type 2 diabetes.

subject areas

  • Animals
  • Cells, Cultured
  • Circadian Rhythm
  • Cryptochromes
  • Cyclic AMP
  • Cyclic AMP Response Element-Binding Protein
  • Gluconeogenesis
  • Liver
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Receptors, G-Protein-Coupled
  • Signal Transduction
scroll to property group menus

Identity

PubMed Central ID

  • PMC2952072

International Standard Serial Number (ISSN)

  • 1078-8956

Digital Object Identifier (DOI)

  • 10.1038/nm.2214

PubMed ID

  • 20852621
scroll to property group menus

Additional Document Info

start page

  • 1152

end page

  • 1156

volume

  • 16

issue

  • 10

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support